Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments ...

Here's the secret for achieving a glowing complexion: there is no secret. In fact, a key factor in achieving great skin at any age comes down to one common denominator that's no secret at all. It's ...

Genmab A/S announced today updated data from cohort B1 of the Phase 1/2 RAINFOL-01 study of rinatabart sesutecan (Rina-S®), an investigational folate receptor-alpha (FR?)-targeted, TOPO1 antibody-drug ...

After hours: March 21 at 7:53:55 PM EDT Loading Chart for TXG ...

Dow Jones stocks gained while Nvidia rose in the stock market today. China stocks fell while Cathie Wood picked more beaten-down stocks.

Find the latest IO Biotech news from Fast company. See related business and technology articles, photos, slideshows and videos.